CLEVERCARDS
Giuseppe Di Marco has joined CleverCards as Senior Vice President for Business Development Europe & Managing Director of CleverCards Italia, from Accel and Battery Ventures-backed, mid-market Spend Management leader, Soldo.
Di Marco led and built the Soldo business in Italy after a successful payments career as CEO of ePay Italy (Euronet: EEFT), CEO of the Zucchetti eCommerce and payments services division (Zucchetti is Italian market leader of ERP and HR software), Managing Director of Lottomatica Payments Services Division (LIS & Totobit Servizi) and Head of QuiGroup Payments Service Division.
CleverCards is a leading global payments platform which makes it possible for anyone, anywhere, anytime, to be paid instantly by enabling businesses, governments and public sector organisations to simply send a digital prepaid Mastercard to an email address or mobile phone number by SMS or WhatsApp, empowering the recipients to spend online, or use their mobile in-store contactlessly using Google Pay, Samsung Pay or Apple Pay immediately.
“The US and European B2B payment markets are highly fragmented and CleverCards is planning to consolidate it through an aggressive buy and build acquisition strategy, driving growth and expansion through digital transformation realising its vision of becoming the ubiquitous global payments platform”, says Kealan Lennon, Founder & CEO of CleverCards.
Earlier this year, CleverCards entered into a definitive agreement to acquire ExpendiaSmart®, a market leader in Europe for Spend Management Solutions and Smart Corporate Cards, along with a Licensed, Electronic Money Institution, subject to regulatory approval.
In February this year, Mastercard and CleverCards signed a strategic partnership and development agreement to expand the usage of digital cards across Europe, a FinTech partnership that provides unprecedented, unique access to Mastercard business development teams in key markets and to key commercial clients.
“Our B2B payments platform is growing exponentially, as organisations seek to manage employee, vendor and customer pay-outs on one platform. CleverCards needed someone with an intimate understanding of the payments industry and a demonstrable ability to rapidly scale a Fintech business. In Giuseppe we’ve found that. His track record speaks for itself and we’re very excited about CleverCards continued European expansion,” adds Lennon.
At CleverCards, Giuseppe will build upon the company’s reputation as a market leader in the corporate sector with Spend Management Solutions and Smart Corporate Cards for employees, drivers and contractors, into the Public Sector with digital Mastercards, empowering social welfare recipients to spend online, or use their mobile in-store contactlessly using Google Pay, Samsung Pay or Apple Pay.
Di Marco comments, “The future of payments is digital. While many companies are scrambling to offer individual B2B solutions, none enable large private or public sector organisations to manage employee, vendor, customer or public sector payments on one platform like CleverCards. We’re providing organisations with greater speed, control and flexibility on pay-outs than ever before. I think that’s a really exciting proposition and both organisations and cardholders love it!”
ENDS
ABOUT CLEVERCARDS
Public and private sector organisations of all sizes use the CleverCards payments platform, making it possible for anyone, anywhere, anytime to be paid instantly, regardless of where they are and without the need for a bank account. Empowered with effortless configuration, customised branding and personalisation, along with elegant mobile-first cardholder experiences, CleverCards uses technology to remove numerous unnecessary processes and participants from the payments value chain, delivering unrivalled efficiencies whilst automating the management of all relevant financial services regulations, including KYC and KYB onboarding, AML and PCI DSS compliance. Since launching its payments platform in December 2019, CleverCards has experienced dramatic growth, with over 5,000 large enterprise businesses and public sector organisations already using the platform. For more information visit www.clevercards.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210708005694/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NHOA Energy Achieves Great Place To Work Certification in Italy, the United States and Australia18.12.2025 10:53:00 CET | Press release
NHOA Energy, global provider of utility-scale energy storage systems, announces that it has been certified Great Place To Work® in Italy, the United States, and Australia. The certification is based entirely on direct feedback from NHOA Energy employees, gathered through an independent and structured listening process. Great Place To Work® Certification™ assesses the quality of the employee experience across key dimensions such as credibility, respect, fairness, pride, and camaraderie. The results achieved by NHOA Energy reflect a corporate culture built on trust, inclusion, and the consistent commitment to valuing people within a dynamic and international environment. Employees highlighted particularly high levels of appreciation for the ethical and transparent behavior of leaders, the welcoming and inclusive approach toward new hires, and fair treatment across diversity, equity, and inclusion dimensions. A strong majority also expressed pride in working at NHOA Energy and reported a
Regnology Signs an Agreement to Acquire Moody’s Regulatory Reporting & ALM Solutions18.12.2025 10:00:00 CET | Press release
The deal further strengthens Regnology’s global position in Regulatory Reporting and significantly accelerates its expansion into new markets Regnology, a leading provider in regulatory, risk, tax, and finance reporting, as well as supervisory technology, today announced it has signed an exclusive agreement for the acquisition of Moody’s Regulatory Reporting & ALM Solutions business, inclusive of solutions for Basel III compliance, IFRS9 impairment accounting, large bank asset-liability management (ALM), Solvency II insurance reporting, and prudential and statistical regulatory reporting across more than 50 jurisdictions. By integrating Moody’s regulatory capital and liquidity capabilities with Regnology’s regulatory, risk, and finance offerings, the firm is creating a unified, scalable platform designed to meet the full spectrum of financial regulatory compliance and risk requirements. This combined strength positions Regnology as the partner of choice for financial institutions seeki
Reply Recognized as a Microsoft Azure Expert Managed Services Provider for the Sixth Consecutive Year18.12.2025 10:00:00 CET | Press release
Reply [EXM, STAR: REY] announced today it has been recognized once again as a Microsoft Azure Expert Managed Services Provider (MSP). The renewal reaffirms Reply’s proven expertise and consistent track record in delivering high-quality cloud solutions and services on the Microsoft Azure platform, powered by the deep technical expertise of its specialized companies – Cluster Reply, Solidsoft Reply and Valorem Reply. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218596617/en/ This recognition reflects the ongoing collaboration between Reply - through its companies Cluster Reply, Solidsoft Reply, and Valorem Reply - and Microsoft, supporting shared efforts to deliver value-driven services to enterprise customers. The Azure Expert MSP program is designed by Microsoft to identify and validate partners with proven capabilities in delivering end-to-end Azure services at scale. To qualify, partners must meet a strict set of requ
Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press release
Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half of study participants treated with zasocitinib achieved clear or almost clear skin (PASI 90), and on average about 30 percent achieved completely clear skin (PASI 100) by week 16 Zasocitinib was generally well-tolerated with a safety profile consistent with previous clinical studies Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at wee
DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 08:30:00 CET | Press release
Based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only medicine to significantly improve overall survival versus chemotherapy in this patient population If approved, DATROWAY could become the standard of care in this setting The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Produc
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom